Sex-Specific Effects Of Endocrine Disruption On Aging And Alzheimer's Disease

Overview

About this study

The researchers are trying to determine whether ovarian hormones are associated with aging processes and with the risk of developing Alzheimer's disease in women.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

* Women who lived in Olmsted County, Minnesota between 1988 and 2007
* Currently aged 55 years and older
* More than six months post chemotherapy or major surgery requiring general anesthesia
* Willing and able to sign informed consent

Exclusion Criteria:

* Not able to read and speak English
* In hospice
* Claustrophobic
* If undergoing Tau imaging, cannot have QT Prolongation

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 08/12/2025. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Neill Graff Radford, M.D.

Open for enrollment

Contact information:

Twila Morrell

morrell.twila@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Kejal Kantarci, M.D.

Closed for enrollment

Contact information:

Sarah Jeno

(507)422-5627

Amundson.Sarah@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20453222

Mayo Clinic Footer